Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
55 Stocks Moving In Monday's Mid-Day Session
04:43pm, Monday, 20'th Apr 2020
Gainers
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares climbed 93.6% to $12.41 after the company announced a collaboration agreement with the University of Edinburgh to...
Genetic Technologies Announces $1.44 Million Registered Direct Offering
12:00pm, Monday, 20'th Apr 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced that it has entered into definitive agreements
35 Stocks Moving in Monday's Pre-Market Session
11:20am, Monday, 20'th Apr 2020
Gainers
American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) shares rose 191.2% to $5.97 in pre-market trading after the company announced collaboration with Cytiva on COVID-...
Genetic Technologies Announces $–.44 Million Registered Direct Offering
12:00am, Monday, 20'th Apr 2020MAC, MRNA among premarket gainers
01:14pm, Friday, 17'th Apr 2020
AMC Entertainment Holdings (NYSE:AMC) +62% on liquidity boost.Genetic Technologies (NASDAQ:GENE) +30% on move into COVID-19 testing.Golden Bull (NASDAQ:DNJR) +28%.Tronox Holdings plc (NYSE:TROX) +19
COVID-19 Testing Capacity at Genetic Technologies Accredited Laboratory
12:00pm, Friday, 17'th Apr 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) has developed a detailed implementation plan to enable a temporary transition of our genetic testing laboratory to a high-thro
Genetic Technologies Announces 'Temporary transition to high throughput Covid-19 testing'
12:00am, Friday, 17'th Apr 2020Genetic Technologies Announces Closing of $1.8 Million Registered Direct Offering
10:00am, Monday, 06'th Apr 2020
MELBOURNE, Australia, April 06, 2020 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests,.
Genetic Technologies Announces Closing of $–.8 Million Registered Direct Offering
12:00am, Monday, 06'th Apr 2020Genetic Technologies Announces $1.8 Million Registered Direct Offering
04:45pm, Wednesday, 01'st Apr 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced that it has entered into definitive agreements
Genetic Technologies Limited Announces Market Update on Sales, Early Test Results and Launch of Consumer Initiated Testing
01:00pm, Wednesday, 01'st Apr 2020
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market. Breast Cancer and Colorectal Cancer tests commissioned
Genetic Technologies Prices ~1.029M ADS Offering At $1.75/ADS
12:00am, Wednesday, 01'st Apr 2020Genetic Technologies Limited Earlier Announces Receipt of Delisting Notification Letter from Nasdaq
12:00am, Monday, 16'th Mar 2020Genetic Technologies Limited Announces Receipt of Delisting Notification Letter from Nasdaq
12:15am, Saturday, 14'th Mar 2020
The Letter indicates that Listing Rule 5815(d)(4)(B) does not permit an issuer that is deficient in stockholders’ equity to present a plan of compliance to the Nasdaq Staff if such issuer has failed
